Prognostic Factors for All Types of Cancer Combined

Flow Cytometrical Analysis of the Human Immune System to Assess Tumor-related Material Piling up in Activated Macrophages in All Relevant Cancer Types.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00704587

Acronym

ProFaCo

Enrollment

520

Registered

2008-06-25

Start date

2006-11-30

Completion date

2015-07-31

Last updated

2016-04-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

cancer occurence, cancer recurrence, neo-adjuvant treatment response measurement

Brief summary

The purpose of this study is to investigate every possible applicability of flow cytometrical analysis in the intracellular detection of tumor-related material in activated macrophages in the broadest range of cancer types.

Interventions

None listed

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* (Suspicion of) presence of cancer in the broadest sense of the word * Must be able to understand and sign written informed consent

Exclusion criteria

* None

Design outcomes

Primary

Measure	Time frame
screening and followup	2 years

Countries

Netherlands

Outcome results